Estanozol as anabolic: a cause of hepatotoxicity
Article Sidebar
How to Cite
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Main Article Content
Abstract
Antibiotics and pain relievers have been frequently described as the main causes of liver toxicity. Anabolic steroids have also been linked to alterations in systems such as cardiovascular or liver. In the latter, they seem to cause cholestasis, hepatocellular carcinoma, nodular regenerative hyperplasia and variceal bleeding secondary to portal hypertension. It is important to consider them as factors associated with hepatotoxicity. The first case in Colombia and one of the few in Latin America of cholestasis associated only to the use of Stanozolol is presented in a 21-year-old patient under treatment with the drug to increase muscle mass. The patient presented with cholestatic liver involvement. Other possible causes of jaundice were ruled out. From the CIOMS / RUCAM scale, causality was established between the consumption of Stanozolol and cholestasis. The objective of this case is to report a case not found in Colombian literature and little reported in world literature.
References
Katarey D, Verma S. Drug-induced liver injury. Clin Med 2016;16:s104-9.
Cho JH, Oh DS, Hong SH, Ko H, Lee NH, Park SE, et al. A nationwide study of the incidence rate of herb-induced liver injury in Korea. Arch Toxicol 2017;91:4009-15.
Alempijevic T, Zec S, Milosavljevic T. Drug-induced liver injury: Do we know everything? World J Hepatol 2017;9:491-502.
Restrepo JC, Muñoz JF, Correa G, Zuleta J, Londoño M, Botero A, et al. Hepatotoxicidad detectada en un hospital de cuarto nivel en la ciudad de Medellín. Acta Médica Colomb 2008;33:261-7.
Espinosa MD. Hepatotoxicidad inducida por zolmitriptán. Gastroenterol Hepatol 2003;26:664.
Pontet Y, Calleri A, Hernández N. Hepatotoxicidad por esteroides anabólicos. An Fac Med (Univ Repúb Urug) 2018;5(2):116-22.
Díaz-García JD, Córdova-Gallardo J, Torres-Viloria A, Estrada-Hernández R, Torre-Delgadillo A. Drug-induced liver injury secondary to anabolic steroid use. Rev Gastroenterol Mex 2020;85:92- 4.
Solimini R, Rotolo MC, Mastrobattista L, Mortali C, Minutillo A, Pichini S, et al. Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping. Eur Rev Med Pharmacol Sci 2017;21:7-16.
Harkin KR, Cowan LA, Andrews GA, Basaraba RJ, Fischer JR, DeBowes LJ, et al. Hepatotoxicity of stanozolol in cats. J Am Vet Med Assoc 2000;217:681-4.
Stȩpień PM, Reczko K, Wieczorek A, Zarȩbska-Michaluk D, Pabjan P, Król T, et al. Severe intrahepatic cholestasis and liver failure after stanozolol usage-case report and review of the literature. Clin Exp Hepatol 2015;1:30-3.
Centre H. Gynaecomastia induced by phenytoin in men with epilepsy Severe cholestasis associated with stanozolol Guillain-Barre syndrome after myocardial infarction 1987;294:4-5.
Quick I. Colestasis inducida por consumo de estanozolol. Revista Española de Enfermedades Digestivas 2006;98:3-4.
Álvarez-Martínez H, Pérez-Campos E. Causalidad en medicina. Gac Med Mex 2004;140:467-72.
Fernández-Pérez L, Flores-Morales A, Chirino-Godoy R, Díaz-Chico JC, Díaz-Chico BN. Steroid binding sites in liver membranes: Interplay between glucocorticoids, sex steroids, and pituitary hormones. J Steroid Biochem Mol Biol 2008;109:336-43.
Andrade RJ, Aithal GP, Björnsson ES, Kaplowitz N, Kullak-Ublick GA, Larrey D, et al. EASL Clinical Practice Guidelines: Drug-induced liver injury. J Hepatol [Internet]. 2019;70:1222-61.
Danan G, Teschke R. RUCAM in drug and herb induced liver injury: The update. International Journal of Molecular Sciences [cited 2020 Dec 8]; Available from: www.mdpi.com/journal/ijms
Ampuero J, García ES, Lorenzo MM, Calle R, Ferrero P, Gómez MR. Stanozolol-induced bland cholestasis. Gastroenterologia y Hepatologia 2014;37:71-2.
El Khoury C, Sabbouh T, Farhat H, Ferzli A. Severe cholestasis and bile cast nephropathy induced by anabolic steroids successfully treated with plasma exchange. Case Rep Med 2017;2017:4296474.
Martínez B, Velazco MJ, Pozo A. Colestasis inducida por consumo de estanozolol. Rev Española Enfermedades Dig 2006;98:219-20.
Yoshida EM, Karim MA, Shaikh JF, Soos JG, Erb SR. At what price, glory? Severe cholestasis and acute renal failure in an athlete abusing stanozolol. CMAJ 1994;151:791-3.
Evely R, Williams R, Triger DR, Milnes J, Low Beer T. Severe cholestasis associated with stanozolol. Br Med J (Clin Res Ed) 1987;294:612-3.
Habscheid W, Abele U, Dahm HH. Anabolic steroids as a cause of severe cholestasis and renal failure in a body builder. Dtsch Medizinische Wochenschrift 1999;124:1029-32.
Most read articles by the same author(s)
- Paulo Andrés Hincapié Morales, Jesús Leonardo García Bastos, Laura Mejía Londoño , Andrea Holguín Tamayo, Paula Andrea Uribe Cárdenas, Nelcy Lorena Valencia Ortiz, Marie Claire Berrouet Mejía, Adverse reactions to beta-lactams: a topic review , Medicina UPB: Vol. 40 No. 1 (2021): January-June
- Andrés Felipe Estrada Atehortúa, Mateo Zuluaga Gómez, Marie Claire Berrouet Mejía, Cyanide poisoning, perspective from the emergency room: report of two cases and literature review , Medicina UPB: Vol. 38 No. 2 (2019): July December
- Alexander López Villarreal, Marie Claire Berrouet Mejía, Cholestasis due to Ligandrol: a case report , Medicina UPB: Vol. 44 No. 1 (2025): January - June
- Marie Claire Berrouet Mejía, Natalia Eugenia Pino Ramos, Marcela Castro Botero, Ubier Eduardo Gómez Calzada, Alterations in the state of consciousness in intoxicated patients , Medicina UPB: Vol. 36 No. 1 (2017): January - June
- Mateo Zuluaga Gómez, Andrés Felipe Estrada Atehortúa, Marie Claire Berrouet Mejía, Intoxication by white phosphorus during Christmas Holidays: a case , Medicina UPB: Vol. 39 No. 1 (2020): January-June
- Santiago Upegui, María Adelaida Orozco Vásquez, Marie Claire Berrouet Mejía, Metformin toxicity, beyond renal failure and lactic acidosis: report of 2 cases , Medicina UPB: Vol. 40 No. 2 (2021): July - December
- Andrés Felipe Estrada Atehortúa, Marie Claire Berrouet Mejía, Jaime Andrés Giraldo, Toxicity by Neonicotinoids: Two Case Reports and Topic Review , Medicina UPB: Vol. 35 No. 1 (2016): January - June
- Johanna Caicedo Valle, Marie Claire Berrouet Mejía, Juan Camilo Saldarriaga Giraldo, The risk of 2,5-dimethoxy-4-bromophenylethylamine (2C-B): Case series , Medicina UPB: Vol. 35 No. 2 (2016): July - December
- Marie Claire Berrouet Mejía, Manuela Lince Restrepo, Diana Restrepo Bernal, Self-medication of analgesics and antibiotics in medical students , Medicina UPB: Vol. 36 No. 2 (2017): July - December
- María Helena Correa García, Cindy Zuluaga Ramírez , Marie Claire Berrouet Mejía, 2-4 dichlorophenoxyacetic acid, a forgotten herbicide: Two case report , Medicina UPB: Vol. 39 No. 2 (2020): July - December